Ultimate Looks Maxing Stack
Skin, body composition & anti-aging in one protocol
Why This Stack Works
GHK-Cu drives collagen synthesis and skin structure via 4,000+ gene pathways. CJC-1295 + Ipamorelin amplify GH pulses for body composition and lean mass. Tirzepatide manages adiposity through dual GIP/GLP-1 agonism.
This combination draws from Anti-Aging, Growth Hormone, Metabolic research, targeting anti-aging, skin, collagen, wound healing, copper peptide, growth hormone. The compounds in this stack act on distinct receptor systems and biological pathways, making them suitable for combined use without mechanism overlap.
All compounds in this stack are supplied by Apollo Peptide Sciences with independent third-party Certificate of Analysis (COA) documentation confirming 99%+ purity. They are sold strictly for laboratory and educational use only and are not FDA-approved for human therapeutic use.
Research Protocol
GHK-Cu: 1–2 mg/day SC or topical. CJC/Ipamorelin blend: per label, 2–3×/week before sleep. Tirzepatide: 2.5–5 mg/week SC. Duration: 16–24 weeks.
Stack Components
GHK-CU
Anti-AgingCopper peptide with powerful anti-aging, collagen synthesis, and wound healing properties.
- Collagen synthesis promotion
- Wound healing acceleration
- Anti-inflammatory effects
- Skin renewal and anti-aging support
CJC1295/Ipamorelin (No DAC)
Growth HormoneCJC-1295 (No DAC) + Ipamorelin blend — synergistic GH secretagogue stack.
- Synergistic growth hormone release
- Minimal cortisol elevation
- Improved body composition
- Better sleep quality
GLP-2 T 15mg
MetabolicDual GIP/GLP-1 receptor agonist for weight management and metabolic health.
- Weight management support
- Improved insulin sensitivity
- Appetite regulation
- Metabolic health optimization
Frequently Asked Questions
What is the Ultimate Looks Maxing Stack?
The Ultimate Looks Maxing Stack is a synergistic research peptide protocol designed for skin, body composition & anti-aging in one protocol. GHK-Cu drives collagen synthesis and skin structure via 4,000+ gene pathways. CJC-1295 + Ipamorelin amplify GH pulses for body composition and lean mass. Tirzepatide manages adiposity through dual GIP/GLP-1 agonism.
What is the protocol for the Ultimate Looks Maxing Stack?
GHK-Cu: 1–2 mg/day SC or topical. CJC/Ipamorelin blend: per label, 2–3×/week before sleep. Tirzepatide: 2.5–5 mg/week SC. Duration: 16–24 weeks. Note: All compounds are for research and laboratory use only and are not intended for human therapeutic application. Consult the relevant preclinical literature before designing any research protocol.
What compounds are in the Ultimate Looks Maxing Stack?
This stack includes GHK-CU, CJC1295/Ipamorelin (No DAC), GLP-2 T 15mg. Key benefits include: GHK-CU: Collagen synthesis promotion; CJC1295/Ipamorelin (No DAC): Synergistic growth hormone release; GLP-2 T 15mg: Weight management support. Each compound targets a distinct mechanism, making them suitable for combined research use without pathway redundancy.
Explore More Stacks
Browse all 9 synergistic peptide protocols or explore the full product catalog.